Italy's biotech sector may have lagged that of other developed countries but change may be afoot as European venture capital firm Sofinnova Partners has launched the country's first biotech accelerator.
Known as BiovelocITA, the accelerator aims to advance research projects that have a strong scientific basis to a proof-of-concept stage...